Vanda Pharmaceuticals (VNDA)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] by (Cboe BZX)
[[ item.lastPrice ]] [[ item.priceChange ]] ([[ item.percentChange ]]) [[ item.tradeTime ]] [NASDAQ]
[[ item.bidPrice ]] x [[ item.bidSize ]] [[ item.askPrice ]] x [[ item.askSize ]]
[[ session ]] [[ item.lastPriceExt ]] [[ item.priceChangeExt ]] ([[ item.percentChangeExt ]]) [[ item.tradeTimeExt ]]
for [[ item.sessionDateDisplayLong ]]
Fiscal Year End Date: 12/31
| 06-2022 | 03-2022 | 12-2021 | 09-2021 | 06-2021 | |
| Assets | |||||
| Current Assets | |||||
| Cash & Cash Equivalents | 58,226 | 66,927 | 52,071 | 50,522 | 57,242 |
| Marketable Securities | 382,632 | 368,249 | 380,742 | 355,446 | 339,251 |
| Receivables | 28,805 | 30,497 | 32,467 | 41,496 | 37,090 |
| Inventories | 1,496 | 1,290 | 1,025 | 902 | 1,055 |
| TOTAL | $496,895 | $492,268 | $478,301 | $461,808 | $446,652 |
| Non-Current Assets | |||||
| PPE Net | 2,746 | 2,917 | 3,113 | 3,318 | 3,631 |
| Intangibles | 19,323 | 19,702 | 20,081 | 20,450 | 20,820 |
| Other Non-Current Assets | 90,138 | 88,671 | 92,297 | 94,191 | 96,542 |
| TOTAL | $112,207 | $111,290 | $115,491 | $117,959 | $120,993 |
| Total Assets | $609,102 | $603,558 | $593,792 | $579,767 | $567,645 |
| Liabilities | |||||
| Current Liabilities | |||||
| Accounts payable and accrued liabilities | 50,236 | 51,394 | 34,438 | 31,820 | 31,788 |
| Accrued Expenses | N/A | N/A | N/A | N/A | 40,201 |
| Other current liabilities | 38,164 | 39,348 | 39,981 | 40,177 | N/A |
| TOTAL | $88,400 | $90,742 | $74,419 | $71,997 | $71,989 |
| Non-Current Liabilities | |||||
| Other Non-Current Liabilities | 12,153 | 10,693 | 14,445 | 14,449 | 14,436 |
| TOTAL | $12,153 | $10,693 | $14,445 | $14,449 | $14,436 |
| Total Liabilities | $100,553 | $101,435 | $88,864 | $86,446 | $86,425 |
| Shareholders' Equity | |||||
| Shares Outstanding, K | 56,561 | 56,490 | 55,907 | 55,712 | 55,638 |
| Common Shares | 57 | 56 | 56 | 56 | 56 |
| Retained earnings | -168,032 | -170,606 | -164,176 | -171,254 | -179,025 |
| Other shareholders' equity | -1,431 | -1,328 | -175 | 111 | 103 |
| TOTAL | $508,549 | $502,123 | $504,928 | $493,321 | $481,220 |
| Total Liabilities And Equity | $609,102 | $603,558 | $593,792 | $579,767 | $567,645 |